LABT Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

9.400

Open

8.850

VWAP

7.96

Vol

4.72M

Mkt Cap

121.26M

Low

7.150

Amount

37.56M

EV/EBITDA(TTM)

Total Shares

14.02M

EV/OCF(TTM)

P/S(TTM)

Events Timeline

(ET)

2026-04-23

10:50:00

Lakewood-Amedex Shares Begin Trading on Nasdaq Today

News

8.5

04-23PRnewswire

PinnedLakewood-Amedex Biotherapeutics Begins Trading on Nasdaq Under LABT

8.5

12:10 PMstocktwits

Lakewood-Amedex Biotherapeutics Listing Accelerates Development of Nu-3

8.5

12:03 PMNASDAQ.COM

Lakewood-Amedex Biotherapeutics Goes Public on Nasdaq

8.5

04-23Newsfilter

Lakewood-Amedex Biotherapeutics Begins Trading on Nasdaq

0 Analyst Rating

Wall Street analysts forecast LABT stock price to rise

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

No data

Valuation Metrics

The current forward P/E ratio for Lakewood-Amedex Biotherapeutics Inc. (LABT.O) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Lakewood-Amedex Biotherapeutics Inc.'s fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

Current PE

NaN

Overvalued PE

Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

Current EV/EBITDA

NaN

Overvalued EV/EBITDA

Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

Current PS

NaN

Overvalued PS

Undervalued PS

Financials

AI Analysis

Annual

Quarterly

Whales Holding LABT

Trading Trends

People Also Watch

Frequently Asked Questions

What is Lakewood-Amedex Biotherapeutics Inc. (LABT) stock price today?

The current price of LABT is 7.34 USD — it has decreased -15.14

What is Lakewood-Amedex Biotherapeutics Inc. (LABT)'s business?

What is the price predicton of LABT Stock?

Wall Street analysts forecast LABT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LABT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Lakewood-Amedex Biotherapeutics Inc. (LABT)'s revenue for the last quarter?

Lakewood-Amedex Biotherapeutics Inc. revenue for the last quarter amounts to NaN USD, decreased

What is Lakewood-Amedex Biotherapeutics Inc. (LABT)'s earnings per share (EPS) for the last quarter?

Lakewood-Amedex Biotherapeutics Inc.. EPS for the last quarter amounts to USD, decreased

How many employees does Lakewood-Amedex Biotherapeutics Inc. (LABT). have?

Lakewood-Amedex Biotherapeutics Inc. (LABT) has 0 emplpoyees as of April 24 2026.

What is Lakewood-Amedex Biotherapeutics Inc. (LABT) market cap?

Today LABT has the market capitalization of 121.26M USD.

LABT Overview

LABT Overview

Events Timeline

News

No data

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Whales Holding LABT

Trading Trends

People Also Watch

Frequently Asked Questions

What is Lakewood-Amedex Biotherapeutics Inc. (LABT) stock price today?

What is Lakewood-Amedex Biotherapeutics Inc. (LABT)'s business?

What is the price predicton of LABT Stock?

What is Lakewood-Amedex Biotherapeutics Inc. (LABT)'s revenue for the last quarter?

What is Lakewood-Amedex Biotherapeutics Inc. (LABT)'s earnings per share (EPS) for the last quarter?

How many employees does Lakewood-Amedex Biotherapeutics Inc. (LABT). have?

What is Lakewood-Amedex Biotherapeutics Inc. (LABT) market cap?